We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT01723306
Brief Title: Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas

First Submitted : November 1, 2012
First Submitted that Met QC Criteria : November 5, 2012
First Posted : November 7, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : June 10, 2016
Last Update Posted : June 14, 2016 (Estimate)